New Delhi witnessed a pivotal moment in India-US relations as Union Science and Technology Minister Dr. Jitendra Singh emphasized that science, technology, and biotechnology form the bedrock of the Comprehensive Global Strategic Partnership between the two nations.
Speaking during a high-level meeting on Monday, Dr. Singh proposed forging a structured India-Delaware partnership in advanced bio-manufacturing. He advocated for converting ongoing discussions on research, manufacturing, and startup ecosystems into tangible outcomes through the formation of a compact working group.
The initiative emerged from talks with a US delegation led by Delaware Governor Matt Meyer, who met Dr. Singh at the Sewa Tirth in the capital. The discussions zeroed in on bilateral cooperation in pharmaceuticals, biotechnology, clean energy, and innovation-driven industrial growth.
Dr. Singh highlighted India’s promising engagement potential with US states boasting robust innovation ecosystems. He showcased India’s ascent as a global hub for biotech and pharmaceutical innovation, spanning from cutting-edge R&D to large-scale, affordable manufacturing.
Pointing to India’s integrated innovation framework linking government, academia, industry, and startups, the minister underscored the Council of Scientific and Industrial Research (CSIR)’s pivotal role. With 37 laboratories and over 7,500 scientists, CSIR anchors most of India’s industrial R&D efforts, contributing significantly to national missions in green hydrogen, quantum technology, life sciences, and biopharmaceuticals, including process development for key drugs.
Delaware’s vibrant bio-science ecosystem offers immense opportunities for collaboration in advanced bio-manufacturing, AI-enabled processes, rapid scale-up technologies, and next-generation biologics and vaccines, Dr. Singh noted. He referenced the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) as a key player. India’s manufacturing prowess, combined with Delaware’s proximity to major US pharma giants, could revolutionize affordable biologics, biosimilars, and vaccines for global health needs.
Governor Meyer praised Delaware’s rich legacy in science and industry, spotlighting its biopharmaceutical manufacturing base, expanding port infrastructure, and business-friendly environment. The delegation, comprising government officials, university representatives, and industry leaders, explored opportunities in clean hydrogen, workforce development, startup promotion, and corporate incorporation frameworks.
This meeting signals a new chapter in Indo-US collaboration, promising breakthroughs that could reshape global innovation landscapes and address pressing health and energy challenges.